SalaryGuide
AboutPricingBlogFor Employers

Marketing jobs

2 marketing jobs

Cencora logo
2 days ago

Senior Director, Marketing Services

Cencora

USA (Remote)Full time$142K/yr – $283K/yr
Cencora logo
4 months ago

Marketing Manager - Production Animal

Cencora

USA (Remote)Full time$89K/yr – $127K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

2 jobs
Cencora logo

Senior Director, Marketing Services

Cencora

USA (Remote)

$142K/yr - $283K/yrIn-houseFull-timeSenior level6+ years exp.
2 days ago
Cencora logo

Marketing Manager - Production Animal

Cencora

USA (Remote)

$89K/yr - $127K/yrIn-houseFull-timeSenior level5+ years exp.
4 months ago
Cencora logo
Cencora

Senior Director, Marketing Services

USA (Remote)

$142K/yr – $283K/yrSenior Level6+ years expFull time

Posted 2 days ago

  • Job
  • Company
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links

Job Summary

Own and evolve a portfolio of marketing services for manufacturer campaigns, lead cross-functional delivery, and translate data into ROI-focused insights while building strong manufacturer partnerships.

  • Lead a team of specialists executing marketing programs
  • Align sales and marketing initiatives with manufacturer partners
  • Drive campaign performance using data-driven insights

Job Description

Responsibilities

  • Own, manage and grow a portfolio of marketing and promotional services including digital, print and event marketing opportunities.
  • Act as both a highly competent representative of our company’s technical abilities and a driver of new capability evolution based on market insights and manufacturer demands.
  • Look outside our company and industry to keep abreast of B2B / B2B2C demand generation strategies.
  • Own industry and general market intelligence on marketing service benchmarks and our businesses’ performance in relation to benchmarks as a method for growing the marketing services programs.
  • Partner with cross-functionally including internal sales, marketing, and IT partners to deliver successful manufacturer campaigns.
  • Align sales initiatives with manufacturer and in house brands marketing initiatives, where appropriate.
  • Partner with manufacturers to co-develop marketing plans that drive mutual success
  • Demonstrate a strong understanding of how to partner with manufacturers to create programs that are in alignment with our business’ operating, financial, sales and profitability goals.
  • Develop creative solutions to the unique business needs of manufacturer partners
  • Utilize data intelligence to track and refine tactics throughout a campaign to drive to campaign KPIs.

Requirements

  • Requires broad experience in fields such as marketing management, business administration, accountancy, sales or similar vocations generally obtained through completion of a four-year Bachelor's Degree Program; MBA with a concentration in Marketing or equivalent preferred.
  • Normally requires six (6) years directly related and progressively responsible experience and 4+ years of experience in a management capacity required.
  • Experience in the animal health industry strongly preferred.
  • Dynamic leadership ability with experience developing high-performance teams.
  • Ability to lead the development of standardized processes and end-to-end solutions.
  • Excellent communication and presentation skills.
  • Experience organizing, planning, and executing large-scale projects.
  • Strong networking and consultative skills with the ability to facilitate groups to a resolution.
  • Ability to exercise independent judgment and creative problem-solving.
  • High degree of technical knowledge of principles in marketing / demand generation strategies

Benefits

  • We provide compensation, benefits, and resources that enable a highly inclusive culture and support our team members’ ability to live with purpose every day.
  • In addition to traditional offerings like medical, dental, and vision care, we also provide a comprehensive suite of benefits that focus on the physical, emotional, financial, and social aspects of wellness.
  • This encompasses support for working families, which may include backup dependent care, adoption assistance, infertility coverage, family building support, behavioral health solutions, paid parental leave, and paid caregiver leave.
  • To encourage your personal growth, we also offer a variety of training programs, professional development resources, and opportunities to participate in mentorship programs, employee resource groups, volunteer activities, and much more.
Cencora logo

Cencora

Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We connect manufacturers, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We also help our partners bring their innovations to patients more efficiently to accelerate positive outcomes. Becoming Cencora has allowed us to combine all the companies and services of AmerisourceBergen. Now, as a unified and internationally inclusive brand, we’re continuing to invest in and focus on our core pharmaceutical distribution business, while also growing our platform of pharma and biopharma services to support pharmaceutical innovation and access. Our 51,000 worldwide team members are shaping the future of healthcare through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen, now Cencora, is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than $290 billion in annual revenue.

Founded in 2022
27K employees (546 in marketing)
www.cencora.com

Salaries

Posted range

$142K/yr – $283K/yr

Taken straight from the job posting.

See all Cencora salaries

Marketing Team

Marketing Team Size
469 (2% of company)
Median Tenure
4.3 years
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$7.8B
Last Raise
$3B
Post IPO Debt, 1 months ago

Funding History

  • Feb 2026
    Post IPO Debt • $3B
  • Dec 2024
    Post IPO Debt • $1.8B
  • Feb 2024
    Post IPO Debt • $500M

Traffic Signals

Monthly Visitors
393.2K
Monthly Google Ads Budget
$17.3K
Traffic Source Mix
Search
26.5%
Direct
56.4%
Referral
10.5%
Social
4.7%
Paid
1.7%

Headcount Trend

Current headcount: ~27.5K

Recent News

Cencora's Healthcare Bio Logistics Strategy
Dec 6, 2025 • Healthcare Digital
How Investors Are Reacting To Cencora (COR) Expanding Global Reach With Alliance Healthcare Acquisition
Nov 27, 2025 • Yahoo Finance
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
Nov 24, 2025 • Yahoo Finance
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
Nov 21, 2025 • Yahoo Finance
Cencora (COR) president Mauch sells $1.86 million in stock
Nov 19, 2025 • Investing.com
Cencora stock reaches all-time high at 368.08 USD
Nov 14, 2025 • Investing.com
How Cencora is Strengthening its US Pharma Distribution
Nov 13, 2025 • Manufacturing Digital Magazine
Cencora Commits $1B to U.S. Distribution Network Expansion
Nov 12, 2025 • Modern Distribution Management
Cencora (COR): Assessing Valuation After Sustained Share Price Growth
Nov 12, 2025 • Yahoo Finance
The 5 Most Interesting Analyst Questions From Cencora’s Q3 Earnings Call
Nov 11, 2025 • Yahoo Finance
Will $1bn Cencora US Expansion Boost Specialty Drug Supply?
Nov 10, 2025 • Supply Chain Digital Magazine
Cencora to invest $1B to bolster pharma network, including in Alabama
Nov 10, 2025 • The Business Journals
Cencora makes $1 billion investment in pharma supply chains
Nov 6, 2025 • FreightWaves
Cencora earmarks $1B to expand US pharmaceutical distribution operations
Nov 6, 2025 • Fierce Pharma
Cencora (COR): $713 Million One-Off Loss Challenges Premium Growth Narrative
Nov 6, 2025 • simplywall.st
Cencora (COR): $713 Million One-Off Loss Challenges Bull Case on Margin Recovery
Nov 6, 2025 • Yahoo Finance
Cencora Expands Dothan Facility With $80 Million Investment
Nov 6, 2025 • Wiregrass Daily News
Cencora to invest $1bn in US pharma distribution network
Nov 6, 2025 • Pharmaceutical Technology
Cencora strengthens specialty healthcare position
Nov 6, 2025 • BioXconomy
Cencora billion-dollar investment will include expanding Dothan facility
Nov 5, 2025 • Business Alabama Magazine
Exclusive | Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain
Nov 5, 2025 • The Wall Street Journal
Cencora’s (NYSE:COR) Q3 Sales Top Estimates
Nov 5, 2025 • Yahoo Finance
Exclusive | Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain
Nov 5, 2025 • The Wall Street Journal
Cencora Announces $1 Billion Investment To Expand U.S. Distribution Infrastructure
Nov 5, 2025 • Pulse 2.0
Cencora Inc (COR) Q4 2025 Earnings Call Highlights: Strategic Investments Propel Growth Amid ...
Nov 5, 2025 • Yahoo Finance
Cencora Posts Loss In Q4; Raises Long-term Guidance
Nov 5, 2025 • Nasdaq
Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast
Nov 5, 2025 • Reuters
Cencora Q4 2025 slides: Double-digit EPS growth, $1B distribution investment planned By Investing.com
Nov 5, 2025 • Investing.com
Cencora makes $1B investment to strengthen U.S. distribution network
Nov 5, 2025 • Drug Store News
Does Cencora’s Latest Acquisition Signal More Upside After a 51.7% 2025 Rally?
Nov 4, 2025 • simplywall.st
Earnings To Watch: Cencora (COR) Reports Q3 Results Tomorrow
Nov 3, 2025 • Yahoo Finance
Cencora (COR) Stock Is Up, What You Need To Know
Oct 30, 2025 • Yahoo Finance
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Oct 29, 2025 • Yahoo Finance
A Fresh Look at Cencora (COR) Valuation as Shares Rally 8% in the Past Month
Oct 26, 2025 • Yahoo Finance
‘Sustainability Could Be In Jeopardy’ – Cencora Evaluates The Current Landscape For US Biosimilars
Oct 22, 2025 • Citeline News & Insights
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
Oct 21, 2025 • Yahoo Finance
Here's Why Cencora (COR) is a Strong Growth Stock
Oct 13, 2025 • Yahoo Finance
NextPharma to sell logistics arm to Cencora
Oct 13, 2025 • The Pharma Letter
Better Business Bureau explains Cencora class action settlement
Oct 6, 2025 • KNOE
Better Business Bureau explains Cencora class action settlement
Oct 6, 2025 • KNOE
$40M Cencora data breach class action settlement
Oct 3, 2025 • Class Action Lawsuits
What is the Cencora Data Security Incident? See if you quality for $5K settlement payout
Sep 30, 2025 • The News Journal
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Sep 26, 2025 • Yahoo Finance
Cencora Inc stock reaches all-time high at 309.38 USD
Sep 24, 2025 • Investing.com
Cencora Stock Surge: Ready for Lift-off?
Sep 23, 2025 • StocksToTrade
Major fund buys $1.9M in Cencora shares amid market moves
Sep 23, 2025 • Rolling Out
Why Cencora (COR) Stock Is Trading Up Today
Sep 23, 2025 • Yahoo Finance
nuVizz to Showcase B2B Last-Mile Delivery Strategies at CSCMP EDGE 2025
Sep 23, 2025 • nuVizz
Kroll Settlement Administration Announces that The Lash Group, LLC Has Reached a Settlement Regarding a Data Security Incident
Sep 23, 2025 • Morningstar.com
Cencora, formerly known as The Lash Group, settles data breach class action lawsuit for $40 million
Sep 19, 2025 • Claim Depot
Kroll Settlement Administration announces that The Lash Group, LLC has reached a Settlement regarding a Data Security Incident
Sep 19, 2025 • Morningstar.com
Kroll Settlement Administration announces that The Lash Group, LLC has reached a Settlement regarding a Data Security Incident
Sep 19, 2025 • PR Newswire
Cencora Stock: Is COR Outperforming the Health Care Sector?
Sep 15, 2025 • Yahoo Finance
Attackers are coming for drug formulas and patient data
Sep 12, 2025 • Help Net Security
Cencora at Baird Global Healthcare Conference: Strategic Growth and Challenges
Sep 9, 2025 • Investing.com
Cencora, Inc. : The calm spell can be taken advantage of to put on new positions
Sep 9, 2025 • MarketScreener
Cencora entered Amendment No. 2 to term credit agreement - SEC filing
Sep 9, 2025 • MarketScreener
Here's Why You Should Hold Cencora Stock in Your Portfolio Now
Sep 5, 2025 • Yahoo Finance
Cencora at Wells Fargo Conference: Strategic Growth and Challenges
Sep 5, 2025 • Investing.com
Here's Why You Should Hold Cencora Stock in Your Portfolio Now
Sep 5, 2025 • Zacks Investment Research
SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER DERIVATIVE ACTION, SETTLEMENT HEARING, AND RIGHT TO APPEAR
Sep 5, 2025 • PR Newswire
Cencora - under proposed settlement of stockholder derivative action, individual defendants will cause $111.25 million to be paid into escrow account
Sep 5, 2025 • MarketScreener
Transcript : Cencora, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-05-2025 08
Sep 5, 2025 • MarketScreener
Global Medication Management Market to grow at 8-9% CAGR,...
Sep 4, 2025 • PharmiWeb
Cencora - agreement to resolve Derivative Action Lebanon County Employees' Retirement Fund v. Steven H. Collis et al., C.A. No. 2021-1118-Jtl
Sep 3, 2025 • MarketScreener
Here's Why Cencora (COR) is a Strong Value Stock
Sep 1, 2025 • Yahoo Finance
Cencora (COR) Appoints D. Mark Durcan As New Chairman Of The Board
Aug 28, 2025 • simplywall.st
Outlook blindsided as FDA blocks wet AMD drug once again
Aug 28, 2025 • pharmaphorum
Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
Aug 27, 2025 • citybiz
Cencora (COR) is an Incredible Growth Stock: 3 Reasons Why
Aug 27, 2025 • Nasdaq
Cencora Appoints Mark Durcan as Chairman
Aug 27, 2025 • MarketScreener
Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
Aug 27, 2025 • Business Wire
Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
Aug 27, 2025 • PharmiWeb
Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
Aug 27, 2025 • Morningstar.com
Cencora Inc appoints D. Mark Durcan as chairman effective Oct 1, 2025
Aug 27, 2025 • MarketScreener
Cencora names Mark Durcan as Chairman of Its Board
Aug 27, 2025 • thefly.com
Five things you need to know today, and the melancholy of endings
Aug 26, 2025 • Seattle TechFlash
Cencora to create Greater Cincinnati facility, add 140 high-paying jobs
Aug 25, 2025 • The Business Journals
Catching Up With Delaware's Chancery Court
Aug 19, 2025 • Law360
State Roundup: Moore Says He’ll Working Toward Affordable Housing; Court: Part Of State Digital Tax Illegal; Rep. Harris Threatens To Help Trump Pull Financial Funds From State ED Dept
Aug 19, 2025 • citybiz
Cencora directors agree to $111M settlement over alleged opioid mismanagement
Aug 18, 2025 • Healthcare Dive
Cencora directors ink $111M deal related to opioid claims
Aug 16, 2025 • Seeking Alpha
Why Cencora (COR) is a Top Value Stock for the Long-Term
Aug 15, 2025 • Yahoo Finance
Cencora Directors Reach $111 Million Deal on Opioid Claims
Aug 15, 2025 • bloomberglaw.com
$111.25M Del. Settlement Proposed For Cencora Opioid Suits
Aug 15, 2025 • Law360
Cencora's (NYSE:COR) Earnings Seem To Be Promising
Aug 14, 2025 • Yahoo Finance
The 5 Most Interesting Analyst Questions From Cencora’s Q2 Earnings Call
Aug 12, 2025 • Yahoo Finance
Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap (NYSE:COR)
Aug 12, 2025 • Seeking Alpha
3 Reasons Growth Investors Will Love Cencora (COR)
Aug 11, 2025 • Yahoo Finance
Cencora & The Lash Group Settle Data Breach Litigation for $40 Million
Aug 11, 2025 • The HIPAA Journal
Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 9, 2025 • simplywall.st
Cencora Q3: Growing Specialty Drug Distributions; Initiate At Buy (NYSE:COR)
Aug 8, 2025 • Seeking Alpha
Cencora Benefits From Strong GLP-1 Sales, Healthy Utilization Trends, and Growing Specialty Assets
Aug 6, 2025 • Morningstar
Cencora (COR) Q3 Earnings and Revenues Surpass Estimates
Aug 6, 2025 • Yahoo Finance
Earnings call transcript: Cencora Inc. beats Q3 2025 expectations, stock dips
Aug 6, 2025 • Investing.com
Cencora weakness after earnings 'overdone,' says Leerink
Aug 6, 2025 • thefly.com
Cencora Reports Fiscal 2025 Third Quarter Results
Aug 6, 2025 • Business Wire
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
Aug 6, 2025 • PR Newswire
Cencora reports Q2 adjusted EPS $4.00, consensus $3.84
Aug 6, 2025 • thefly.com
Cencora, Inc. Declares Quarterly Cash Dividend, Payable on September 3, 2025
Aug 6, 2025 • MarketScreener

Links

www.cencora.comLinkedInX (Twitter)Crunchbase